Head-to-head · Cost-Efficiency Index
Basal Health vs LifeMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Basal Health
Cost-first shoppers who want a low, clearly-labeled first-month tirzepatide rate — if you can tolerate not knowing what month two costs before you sign up.
Visit Basal HealthLifeMD
Cost-first shoppers who want insured shoppers chasing a low branded-GLP-1 copay, who understand the program fee and medication cost are billed separately.
Visit LifeMDThe verdict
Basal Health and LifeMD tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with Basal Health (ranked #247, a hair above #252) — Cost-first shoppers who want a low, clearly-labeled first-month tirzepatide rate — if you can tolerate not knowing what month two costs before you sign up. But LifeMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Basal Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Basal Health | LifeMD |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 60/100 |
| Semaglutide / mo | Not disclosed | $298/mo (brand Wegovy) |
| Tirzepatide / mo | $99/mo (first-month rate, compounded) | $498/mo (brand Zepbound, plus a separate fee) |
| Semaglutide / yr (modeled) | — | $3,576 |
| Tirzepatide / yr (modeled) | $1,188 | $5,976 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #247 | #252 |
Basal Health
60/100Where the value is
- Stated nationwide coverage — 'all 50 U.S. states and the District of Columbia' — confirmed in the footer disclaimer
- LegitScript Certified badge displayed
- The $99 first-month price is at least labeled honestly as a first-month rate rather than implied to be the standing price
The tradeoffs
- The $99 figure is explicitly first-month only; the ongoing monthly price is never disclosed anywhere on the public site
- No semaglutide pricing (or confirmation semaglutide is even offered) was found — only tirzepatide is named
LifeMD
60/100Where the value is
- LegitScript certified, publicly traded (NASDAQ: LFMD), with its own affiliated pharmacy processing up to 5,000 scripts/day
- Sells FDA-approved branded Wegovy and Zepbound rather than compounded copies, in both pill and pen formats for Wegovy
- Insured patients may pay as little as $0-25 per fill via manufacturer savings-card integration
The tradeoffs
- The program fee and the medication cost are billed completely separately, and both are labeled with overlapping $149 figures — a shopper reading either number alone will underestimate the real monthly cost by roughly half
- The advertised '$39 first month' is a one-time discount on the program fee only; the standing program fee is $149/month starting month two
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.